Would think the odds are a strong yes.
With in the least, reduce Keys toxic profile.
Sure it's highly likely Dr.'s J & Pestell, have time ago, already discussed with Merck, every one of the LL/Key combo benefits.
Of course same with every other ICI.
Including any pharma interested in wanting to enter the LL & LL/ICI combo markets
Especially after the LL affect on Tecentriq news. A medical mind blower....
_____
Keytruda's linked to Serious mentions section:
https://www.legalmatch.com/law-library/articl...wyers.html